Robert Balshaw

5.0k total citations
146 papers, 3.5k citations indexed

About

Robert Balshaw is a scholar working on Epidemiology, Surgery and Transplantation. According to data from OpenAlex, Robert Balshaw has authored 146 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 28 papers in Surgery and 24 papers in Transplantation. Recurrent topics in Robert Balshaw's work include Renal Transplantation Outcomes and Treatments (24 papers), Acute Ischemic Stroke Management (11 papers) and Transplantation: Methods and Outcomes (9 papers). Robert Balshaw is often cited by papers focused on Renal Transplantation Outcomes and Treatments (24 papers), Acute Ischemic Stroke Management (11 papers) and Transplantation: Methods and Outcomes (9 papers). Robert Balshaw collaborates with scholars based in Canada, United States and Switzerland. Robert Balshaw's co-authors include Paul Keown, Olaf Heisel, Bruce M. McManus, Raymond T. Ng, David Ames, Henry Brodaty, Mark Woodward, Karyn Boundy, Zsuzsanna Hollander and J. Wilson-McManus and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Robert Balshaw

139 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Balshaw Canada 31 825 795 777 571 441 146 3.5k
Philip D. Walson United States 33 447 0.5× 668 0.8× 578 0.7× 459 0.8× 349 0.8× 147 3.3k
Kenneth D. Chavin United States 47 1.3k 1.5× 2.5k 3.1× 1.6k 2.1× 1.0k 1.8× 293 0.7× 244 6.7k
Jerzy Chudek Poland 34 1.1k 1.4× 705 0.9× 256 0.3× 972 1.7× 196 0.4× 410 5.4k
Chih‐Wei Yang Taiwan 27 665 0.8× 747 0.9× 91 0.1× 909 1.6× 144 0.3× 81 5.3k
Joel Neugarten United States 40 332 0.4× 582 0.7× 250 0.3× 661 1.2× 93 0.2× 82 4.6k
Toshiki Moriyama Japan 43 691 0.8× 738 0.9× 189 0.2× 1.3k 2.2× 83 0.2× 220 5.5k
Robert Luke United States 36 186 0.2× 546 0.7× 561 0.7× 681 1.2× 298 0.7× 158 3.9k
Barbara Grimes United States 40 401 0.5× 595 0.7× 147 0.2× 278 0.5× 232 0.5× 123 3.7k
Silvia De Rosa Italy 22 766 0.9× 916 1.2× 101 0.1× 683 1.2× 91 0.2× 110 5.3k
Michał Nowicki Poland 27 345 0.4× 483 0.6× 128 0.2× 299 0.5× 73 0.2× 221 2.9k

Countries citing papers authored by Robert Balshaw

Since Specialization
Citations

This map shows the geographic impact of Robert Balshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Balshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Balshaw more than expected).

Fields of papers citing papers by Robert Balshaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Balshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Balshaw. The network helps show where Robert Balshaw may publish in the future.

Co-authorship network of co-authors of Robert Balshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Balshaw. A scholar is included among the top collaborators of Robert Balshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Balshaw. Robert Balshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Emmett Tsz Yeung, Robert Balshaw, Ian W. Gibson, et al.. (2024). HLA-DQ de novo donor-specific antibody development and its effect on renal allograft survival. Human Immunology. 85. 110989–110989.
2.
Balshaw, Robert, Emily Rimmer, Murdoch Leeies, et al.. (2024). Red blood cell transfusion and the use of intravenous iron in iron‐deficient patients presenting to the emergency department. SHILAP Revista de lepidopterología. 6(1). e1061–e1061. 1 indexed citations
3.
Sbihi, Hind, Julia L. MacIsaac, Robert Balshaw, et al.. (2024). Persistent DNA Methylation Changes across the First Year of Life and Prenatal NO2 Exposure in a Canadian Prospective Birth Study. Environmental Health Perspectives. 132(4). 47004–47004. 2 indexed citations
4.
Wiebe, Chris, Robert Balshaw, Jared Bullard, et al.. (2024). Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients. Clinical Transplantation. 38(5). e15329–e15329. 5 indexed citations
5.
6.
Houston, Brett L., Weiping Teng, Robert Balshaw, et al.. (2023). OC 05.2 Impact of Heparin on Disease State Transition in Hospitalized, Non-Critically Ill Patients with COVID-19; Secondary Analysis of an International Multi-Platform RCT. Research and Practice in Thrombosis and Haemostasis. 7. 100360–100360. 2 indexed citations
7.
8.
Wiebe, Chris, Robert Balshaw, Ian W. Gibson, et al.. (2023). A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression. American Journal of Transplantation. 23(12). 1882–1892. 9 indexed citations
9.
Mollard, Rebecca C., Bohdan L. Luhovyy, Heather Martin, et al.. (2023). Reducing Dietary Acid With Fruit and Vegetables Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD): A Clinical Research Protocol. Canadian Journal of Kidney Health and Disease. 10. 1035145380–1035145380. 1 indexed citations
10.
Houston, Brett L., Dean Fergusson, Jamie Falk, et al.. (2021). Prophylactic tranexamic acid use in non‐cardiac surgeries at high risk for transfusion. Transfusion Medicine. 31(4). 236–242. 6 indexed citations
11.
Singh, Amrit, Casey P. Shannon, Chen Xi Yang, et al.. (2017). Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic Response. American Journal of Respiratory and Critical Care Medicine. 197(4). 450–462. 16 indexed citations
12.
Hollander, Zsuzsanna, Marie Lazárová, Karen Lam, et al.. (2014). Proteomic Biomarkers of Recovered Heart Function. European Journal of Heart Failure. 16(5). 551–559. 10 indexed citations
13.
Freue, Gabriela V. Cohen, Anna Meredith, Oliver P. Günther, et al.. (2010). Proteomic Signatures in Plasma during Early Acute Renal Allograft Rejection. Molecular & Cellular Proteomics. 9(9). 1954–1967. 76 indexed citations
14.
Günther, Oliver P., David Lin, Robert Balshaw, et al.. (2010). Effects of Sample Timing and Treatment on Gene Expression in Early Acute Renal Allograft Rejection. Transplantation. 91(3). 323–329. 4 indexed citations
15.
Hollander, Zsuzsanna, David Lin, Virginia Chen, et al.. (2010). Whole Blood Biomarkers of Acute Cardiac Allograft Rejection: Double-Crossing the Biopsy. Transplantation. 90(12). 1388–1393. 21 indexed citations
16.
Balshaw, Robert, et al.. (2009). Longitudinal Outcomes of GastroIntestinal symptoms in Canada (LOGIC): key factors for an effective patient retention in observational studies.. PubMed. 16(1). e140–50. 1 indexed citations
17.
Günther, Oliver P., Robert Balshaw, Andreas Scherer, et al.. (2009). Functional Genomic Analysis of Peripheral Blood During Early Acute Renal Allograft Rejection. Transplantation. 88(7). 942–951. 30 indexed citations
18.
Deschênes, Marc, Eric M. Yoshida, Kevork Peltekian, et al.. (2007). [615] MANAGEMENT OF CHRONIC HEPATITIS C IN A DIVERSE POPULATION WITH PEGINTERFERON tt-2a AND RIBAVIRIN: FINAL RESULTS OF THE CANADIAN PEGASYS EXPANDED ACCESS PROGRAM (EAP). Journal of Hepatology. 46. S232–S233. 2 indexed citations
19.
Дмитриенко, С. В., et al.. (2007). The use of consensus guidelines for management of cytomegalovirus infection in renal transplantation. Kidney International. 72(8). 1014–1022. 11 indexed citations
20.
Sherman, Morris, Eric M. Yoshida, Marc Deschênes, et al.. (2006). Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. Gut. 55(11). 1631–1638. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip D. Walson Breakdown of academic impact, for papers by Kenneth D. Chavin Breakdown of academic impact, for papers by Jerzy Chudek Breakdown of academic impact, for papers by Chih‐Wei Yang Breakdown of academic impact, for papers by Joel Neugarten Breakdown of academic impact, for papers by Toshiki Moriyama Breakdown of academic impact, for papers by Robert Luke Breakdown of academic impact, for papers by Barbara Grimes Breakdown of academic impact, for papers by Silvia De Rosa Breakdown of academic impact, for papers by Michał Nowicki
Rankless by CCL
2026